Navigation Links
Scotland opens stem cell research center and bio-medical incubator
Date:5/29/2012

EDINBURGH, Scotland, May 29, 2012 /PRNewswire/ -- Research into conditions such as multiple sclerosis and heart and liver disease will benefit from multi-million dollar stem cell research and life sciences facilities opened yesterday by HRH, the Princess Royal.

The Princess Royal is to unveil plaques this afternoon at the $85 million Scottish Centre for Regenerative Medicine (SCRM) and $38 million bio-incubator facility, Nine, in Edinburgh.

The University of Edinburgh's Scottish Centre for Regenerative Medicine will carry out cutting-edge stem cell research to help find therapies for patients with conditions such as multiple sclerosis, Parkinson's disease, motor neurone disease, and heart and liver diseases.

The centre is the first large-scale, purpose-built facility of its kind and provides accommodation for up to 250 stem cell scientists. The centre, funded by the University of Edinburgh, Scottish Enterprise, the Medical Research Council (MRC) and the British Heart Foundation through its Mending Broken Hearts Appeal, was opened by the Princess Royal in her role as Chancellor of the University. It includes the most up-to-date facilities in the UK, which meet the highest guidelines, to manufacture stem cell lines that could be used for patient therapies.

Nine, which has been jointly funded by Scottish Enterprise and the UK Government's Department for Business, Innovation and Skills, provides 85,000 square feet of laboratory and office space for both established biotechnology companies and start-up ventures. These could include potential spin-out companies from the University of Edinburgh.

Both buildings form a major investment in research at Edinburgh BioQuarter, which is in the city's Little France area and encompasses the Royal Infirmary of Edinburgh and the University of Edinburgh's Queen's Medical Research Institute and Chancellor's Building.

Professor Charles french-Constant, Director of the Medical Research Council Centre for Regenerative Medicine at the SCRM and Chair of Medical Neurology at the University of Edinburgh, said: "Recent research into stem cells has heralded the beginning of a revolution in modern medicine. The Scottish Centre for Regenerative Medicine's great strength lies in bringing world-class clinicians and scientists to work together, encouraging the translation of laboratory discoveries into treatments for patients. The research will help in finding treatments for devastating conditions, for which there are currently no cures."

Jim McFarlane, Managing Director of Operations at Scottish Enterprise said: "Scotland has a distinguished history in developing breakthroughs in medical science and we believe that, collectively, the concentration of world-class research and facilities at Edinburgh BioQuarter will provide a breeding ground conducive to new medical discoveries that will continue that tradition for centuries to come and have a significant impact on the Scottish economy.

"Already, Nine has secured its first tenants and is attracting significant interest from potential occupiers from Scotland's life sciences sector. The official opening of the bio-incubator facility marks a major milestone in cementing Scotland's global reputation for excellence in commercialization of medical research."

Edinburgh BioQuarter is a joint venture between NHS Lothian, Scottish Enterprise, the University of Edinburgh and Alexandria Real Estate Equities, to boost developments in life sciences. This includes assisting the formation of spin-out companies from NHS and University of Edinburgh research, as well as encouraging partnerships with the bio-pharmaceutical industry.

For more information please contact:

Nine, The BioQuarter
Aileen Hotchkiss, Press Office, Scottish Enterprise, 07795 121 565
aileen.hotchkiss@scotent.co.uk

 

 


'/>"/>
SOURCE Scottish Enterprise
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Scotland Announces Goal to Double Life Sciences Contribution to Scottish Economy by 2020 at BIO
2. Scotland Announces New Life Science Leadership and Investments at BIO 2010
3. Scotland Launches Chemicals Industry Partnerships To Propel $13 Billion Sector
4. Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research
5. Data mining opens the door to predictive neuroscience
6. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
7. Discovery opens door to low-cost negative refraction, new products and industries
8. PRA Opens Office in Singapore
9. Stevenage Bioscience Catalyst Opens With Exciting Year Ahead
10. Alchem International Opens Sales and Marketing Office in the U.S.
11. CoreLab Partners Opens Office in Tokyo, Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... Research and Markets has announced the addition of the ... 2021" report to their offering. ... The biosimilars market is expected to reach ... at a CAGR of 26.3%. The global biosimilars ... application. Factors such as rising incidence of various diseases, increasing demand ...
(Date:1/12/2017)... ... January 12, 2017 , ... MEXICO’S ... Technologies, Inc., announces the successful outcome of the first lumbar fusion procedure ... (Vertebral Technologies, Inc.) has partnered with Mexico-based medical product company BioMedical Technologies ...
(Date:1/12/2017)... 2017 The Energy and Resources ... for producing mycorrhizae. The Centre for Mycorrhizal Research at ... mycorrhizae and developed a technology that eventually produces mycorrhizae ... ... The TERI facility has a production capacity of ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... journal Clinical Cancer Research show early promise of the investigational anti-cancer agent tucatinib ... a median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated patients ...
Breaking Biology Technology:
(Date:12/16/2016)... MIAMI , Dec. 16, 2016   ... intuitive Identity management products and solutions and a ... announced today that it is offering seamless, integrated ... Edam security entrance products. The solutions provide IdentyTech,s ... to secure their facilities from crime and theft. ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... 14, 2016 "Increase in mobile transactions is ... mobile biometrics market is expected to grow from USD ... 2022, at a CAGR of 29.3% between 2016 and ... the growing demand for smart devices, government initiatives, and ... "Software component is expected to grow at a high ...
Breaking Biology News(10 mins):